Protalix BioTherapeutics, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for Protalix BioTherapeutics, Inc. (PLX) is 11.68

According to Protalix BioTherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 11.68. This represents a change of -75.48% compared to the average of 47.63 of the last 4 quarters.

Protalix BioTherapeutics, Inc. (PLX) Historical PE Ratio (quarterly & annually)

How has PLX PE Ratio performed in the past?

The mean historical PE Ratio of Protalix BioTherapeutics, Inc. over the last ten years is -0.31. The current 11.68 PE Ratio has changed -382747.96% with respect to the historical average. Over the past ten years (40 quarters), PLX's PE Ratio was at its highest in in the June 2025 quarter at 176.19. The PE Ratio was at its lowest in in the September 2023 quarter at -16.21.

Protalix BioTherapeutics, Inc. (PLX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Protalix BioTherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Protalix BioTherapeutics, Inc. (PLX) Average PE Ratio

How has PLX PE Ratio performed in the past?

The current PE Ratio of Protalix BioTherapeutics, Inc. (PLX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Protalix BioTherapeutics, Inc. (PLX) PE Ratio vs. Peers

How is PLX’s PE Ratio compared to its peers?

Protalix BioTherapeutics, Inc.’s PE Ratio is greater than SELLAS Life Sciences Group, Inc. (-35.26), greater than Coherus Oncology, Inc. (-1.16), greater than Invivyd, Inc. (-2.59), greater than Protara Therapeutics, Inc. (-2.73), greater than Genfit S.A. (-6.20), greater than Codexis, Inc. (-7.02), greater than OmniAb, Inc. (-5.09), greater than Neonc Technologies Holdings, Inc. (-2.72), greater than MediWound Ltd. (-6.30), greater than Sangamo Therapeutics, Inc. (-0.45),

Build a custom stock screener for Protalix BioTherapeutics, Inc. (PLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protalix BioTherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Protalix BioTherapeutics, Inc. (PLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Protalix BioTherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.